About: XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk) կլինիկական փորձարկում (hy)
rdfs:label	XERECEPT® (nl) XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema (en)
skos:prefLabel	XERECEPT® (nl) XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema (en)
name	XERECEPT® (nl) XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema (en)
title	wds:Q65543128-E9868CB6-3EEE-4FDE-BA86-2C861C5C4AA1
title	A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptoms Associated With Peritumoral Brain Edema in Patients With Primary Malignant Glioma (en)
instance of	wds:Q65543128-9DE700A0-1DC1-42F4-869B-4D5BC5FB7A1F
instance of	clinical trial
start time	wds:Q65543128-7EC22076-66C0-484C-8379-91AA3B292D8C
start time	2006-01-01 00:00:00Z (xsd:dateTime)
country	wds:Q65543128-05ACE9BA-80E8-45BD-8256-2473312DA95A wds:Q65543128-AA5CD2C9-C172-42C9-BDE2-FAAEA117854F
country	Malawi United States of America
research site	wds:Q65543128-09735E87-5091-4A44-A472-2B0A9023A26F wds:Q65543128-1D7968ED-EE32-49CA-B19F-14A2078649EC wds:Q65543128-2BDDA04C-249A-4163-B21A-C12B04A66337 wds:Q65543128-37C7393F-7DCD-4831-839A-BA3E0E0364EF wds:Q65543128-43ACE088-8F7E-4824-8A9C-0FBC2CBCEB34 wds:Q65543128-442A6E53-DC4A-445B-9DD2-FCFAE1D67D11 wds:Q65543128-51221BD2-D784-4FC8-9357-30D6C35122C0 wds:Q65543128-78C5A85B-607F-4EDE-934F-3CF6EDDD640D wds:Q65543128-9A2C9A3F-7E0E-4372-8746-D667C407FF9F wds:Q65543128-B7D5D9C2-7B10-48BE-998E-DF2F2842FD67 wds:Q65543128-DB286964-5E55-4824-8840-2C4EA3C63641
research site	University of Wisconsin–Madison Cross Cancer Institute Wake Forest University Cornell University Vanderbilt University Medical Center Ohio State University Medical College of Wisconsin Hoag Memorial Hospital Presbyterian Barrow Neurological Institute Emory University Dent Neurologic Institute
research intervention	wds:Q65543128-4C78C874-86AE-4961-9A6F-5996A741BED0
research intervention	(RS)-cyclophosphamide
minimum age	wds:Q65543128-9535454A-C20E-43EB-8EAB-13BBB160D6EE
minimum age	18 (xsd:decimal)
number of participants	wds:Q65543128-869CDF5D-7606-4614-8DFB-6335521D4690
number of participants	120 (xsd:decimal)
contributor to the...e work or subject	wds:Q65543128-2AB77BAB-43DF-4770-A86F-FC4D3F25ACBC
contributor to the...e work or subject	Neurobiological Technologies
study type	wds:Q65543128-23BD821E-AE63-4EB7-9279-AB6DCBC202B5
study type	interventional study
ClinicalTrials.gov ID	wds:Q65543128-FE29F7A4-1BD0-48CF-945A-FA6CBB2588AD
ClinicalTrials.gov ID	NCT00226668
clinical trial phase	wds:Q65543128-98420EE5-85CE-422F-9F87-E61F626E5407
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65543128

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software